At the end of this activity, participants will be able to: 1. Identify how CGMs can assist with insulin de-escalation. 2. Demonstrate strategies for medication de-escalation in diabetes management based on CGM data. 3. Identify how to de-escalate oral medications and insulin when initiating GLP-1 or dual GLP-1/GIP RA therapy. 4. Identify key patient education strategies for restarting GLP-1 or dual GLP-1/GIP RA after a treatment lapse.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
89% of listed courses are free
31 of 35 courses listed here are free.
Collected from the provider’s public pages · source
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 1 credit
- MOC · Up to 1 point
-
ReleasedNov 17, 2025
-
Last day to claim creditDec 1, 2026 7 weeks left
-
Cardiometabolic Health Congress (CMHC) +1 Integrating CGM with GLP-1 RA Therapy: Clinical Evidence, Treatment Planning, and Overcoming Barriers in Managing T2DM
-
Physicians’ Education Resource From Numbers to Navigation: Translating Data From Diabetes Technologies into Optimized Decision-Making
-
SSM Health SM-M Grand Rounds “GLP1s: Stealing the Spotlight: The “Skinny” for Healthcare Providers”
-
American Diabetes Association Focus on Diabetes: Enhancing Communication Among Eye Health Specialists, Primary Care Providers, and Endocrinologists
-
American Diabetes Association Type 1 Diabetes Technologies
-
American Diabetes Association Empowered Care in GDM: Overcoming Bias and Supporting High-Risk Populations During Pregnancy
